Sio Gene Therapies Inc

NASDAQ:SIOX  
2.14
+0.07 (+3.38%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Sio Gene Therapies Inc Stock, NASDAQ:SIOX

130 West 42nd Street, 26th floor, New York, New York 10036
United States of America
Phone: +1.877.746.4891
Number of Employees: 38

Description

Sio Gene Therapies Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease. Axovant operates through seven wholly owned subsidiaries and also has business operations in Basel, Switzerland and New York, NY. The company was founded on October 31, 2014 and is headquartered in New York, NY.